Japanese drugmaker Shionogi & Co. Ltd. says sales of the Covid pill it is developing could reach $2 billion drug. The company expects to have late-stage trial data in Japan by December and plans to …
( read original story …)
The Japan News
Japanese drugmaker Shionogi & Co. Ltd. says sales of the Covid pill it is developing could reach $2 billion drug. The company expects to have late-stage trial data in Japan by December and plans to …
( read original story …)